84 related articles for article (PubMed ID: 21965782)
1. Immunohistochemical expression and prognostic significance of CCND3, MCM2 and MCM7 in Hodgkin lymhoma.
Marnerides A; Vassilakopoulos TP; Boltetsou E; Levidou G; Angelopoulou MK; Thymara I; Kyrtsonis MC; Pappi V; Tsopra O; Panayiotidis P; Pangalis GA; Beris P; Patsouris E; Korkolopoulou P
Anticancer Res; 2011 Oct; 31(10):3585-94. PubMed ID: 21965782
[TBL] [Abstract][Full Text] [Related]
2. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H
Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445
[TBL] [Abstract][Full Text] [Related]
3. Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion.
Lau KM; Chan QK; Pang JC; Li KK; Yeung WW; Chung NY; Lui PC; Tam YS; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Oncogene; 2010 Oct; 29(40):5475-89. PubMed ID: 20661220
[TBL] [Abstract][Full Text] [Related]
4. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
[TBL] [Abstract][Full Text] [Related]
5. Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
Sup SJ; Alemañy CA; Pohlman B; Elson P; Malhi S; Thakkar S; Steinle R; Hsi ED
J Clin Oncol; 2005 Jun; 23(16):3773-9. PubMed ID: 15809450
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features.
Møller MB; Nielsen O; Pedersen NT
Am J Clin Pathol; 2001 Mar; 115(3):404-12. PubMed ID: 11242797
[TBL] [Abstract][Full Text] [Related]
7. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance.
Nishihara K; Shomori K; Fujioka S; Tokuyasu N; Inaba A; Osaki M; Ogawa T; Ito H
Int J Oncol; 2008 Aug; 33(2):245-51. PubMed ID: 18636144
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
[TBL] [Abstract][Full Text] [Related]
10. MCM7 expression predicts post-operative prognosis for hepatocellular carcinoma.
Zhou YM; Zhang XF; Cao L; Li B; Sui CJ; Li YM; Yin ZF
Liver Int; 2012 Nov; 32(10):1505-9. PubMed ID: 22784096
[TBL] [Abstract][Full Text] [Related]
11. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphoma.
Doussis-Anagnostopoulou IA; Vassilakopoulos TP; Thymara I; Korkolopoulou P; Angelopoulou MK; Siakantaris MP; Kokoris SI; Dimitriadou EM; Kalpadakis C; Matzouranis M; Kaklamanis L; Panayiotidis P; Kyrtsonis MC; Androulaki A; Patsouris E; Kittas C; Pangalis GA
Clin Cancer Res; 2008 Mar; 14(6):1759-66. PubMed ID: 18347177
[TBL] [Abstract][Full Text] [Related]
13. Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study.
Tamura T; Shomori K; Haruki T; Nosaka K; Hamamoto Y; Shiomi T; Ryoke K; Ito H
J Oral Pathol Med; 2010 Apr; 39(4):328-34. PubMed ID: 20136698
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of minichromosome maintenance protein 7 as a prognostic marker in canine cutaneous mast cell tumours.
Berlato D; Stewart J; Newton R; Maglennon GA; Monti P; Flindall A; Murphy S
Vet Comp Oncol; 2012 Jun; 10(2):135-42. PubMed ID: 22235877
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
Liu DC; Yang ZL
Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
[TBL] [Abstract][Full Text] [Related]
17. Replication protein A: a reliable biologic marker of prognostic and therapeutic value in human astrocytic tumors.
Kanakis D; Levidou G; Gakiopoulou H; Eftichiadis C; Thymara I; Fragkou P; Trigka EA; Boviatsis E; Patsouris E; Korkolopoulou P
Hum Pathol; 2011 Oct; 42(10):1545-53. PubMed ID: 21496876
[TBL] [Abstract][Full Text] [Related]
18. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
[TBL] [Abstract][Full Text] [Related]
19. The topoisomerase IIalpha expression correlates with survival in patients with advanced Hodgkin's lymphoma.
Provencio M; Corbacho C; Salas C; Millan I; Espana P; Bonilla F; Ramon Cajal S
Clin Cancer Res; 2003 Apr; 9(4):1406-11. PubMed ID: 12684412
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA
Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
